BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32263770)

  • 21. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.
    Grifantini R; Taranta M; Gherardini L; Naldi I; Parri M; Grandi A; Giannetti A; Tombelli S; Lucarini G; Ricotti L; Campagnoli S; De Camilli E; Pelosi G; Baldini F; Menciassi A; Viale G; Pileri P; Cinti C
    J Control Release; 2018 Jun; 280():76-86. PubMed ID: 29733876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic modifications of metastasis suppressor genes in colon cancer metastasis.
    Li Q; Chen H
    Epigenetics; 2011 Jul; 6(7):849-52. PubMed ID: 21758003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of novel chemotherapeutic delivery systems for colon cancer therapy based on oral polymeric nanoparticles.
    Mishra B; Chaurasia S
    Ther Deliv; 2017 Jan; 8(1):29-47. PubMed ID: 27982736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Getting into the colon: approaches to target colorectal cancer.
    Patel MM
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1343-50. PubMed ID: 24898947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer.
    Tsai KW; Lo YH; Liu H; Yeh CY; Chen YZ; Hsu CW; Chen WS; Wang JH
    Mol Cancer; 2018 Mar; 17(1):72. PubMed ID: 29523145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery.
    van Vlerken LE; Amiji MM
    Expert Opin Drug Deliv; 2006 Mar; 3(2):205-16. PubMed ID: 16506948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological and dietary factors in prevention of colorectal cancer.
    Waluga M; Zorniak M; Fichna J; Kukla M; Hartleb M
    J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30149368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of iron oxide core of polymeric nanoparticles in the thermosensitivity of colon cancer cell line HT-29.
    Esmaelbeygi E; Khoei S; Khoee S; Eynali S
    Int J Hyperthermia; 2015; 31(5):489-97. PubMed ID: 25960148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular therapy of colorectal cancer: progress and future directions.
    Weng W; Feng J; Qin H; Ma Y
    Int J Cancer; 2015 Feb; 136(3):493-502. PubMed ID: 24420815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal carcinogenesis--update and perspectives.
    Raskov H; Pommergaard HC; Burcharth J; Rosenberg J
    World J Gastroenterol; 2014 Dec; 20(48):18151-64. PubMed ID: 25561783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
    Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
    Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms.
    Yin TF; Wang M; Qing Y; Lin YM; Wu D
    World J Gastroenterol; 2016 Aug; 22(31):7058-68. PubMed ID: 27610016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of cancer stem cells in pathogenesis of colorectal cancer.
    Szaryńska M; Olejniczak A; Kmieć Z
    Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1469-1482. PubMed ID: 28100854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticulate Drug Delivery to Colorectal Cancer: Formulation Strategies and Surface Engineering.
    Tran TT; Tran PH; Wang Y; Li P; Kong L
    Curr Pharm Des; 2016; 22(19):2904-12. PubMed ID: 26898738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.
    Krishnaiah YS; Khan MA
    Pharm Dev Technol; 2012; 17(5):521-40. PubMed ID: 22681390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoprevention of colorectal cancer: ready for routine use?
    Arber N; Levin B
    Curr Top Med Chem; 2005; 5(5):517-25. PubMed ID: 15974946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Near infra-red polymeric nanoparticle based optical imaging in Cancer diagnosis.
    Perumal V; Sivakumar PM; Zarrabi A; Muthupandian S; Vijayaraghavalu S; Sahoo K; Das A; Das S; Payyappilly SS; Das S
    J Photochem Photobiol B; 2019 Oct; 199():111630. PubMed ID: 31610429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival.
    Yu H; Jiang W; Chen G; Yang F; Zhao X; Ji Z; Ni J; Fu Y; Chen F; Zhao B
    Med Sci Monit; 2019 May; 25():3549-3557. PubMed ID: 31083646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.